Ly and Ia antigen phenotypes of T cells involved in delayed-type hypersensitivity and in suppression.

PubWeight™: 3.00‹?› | Rank: Top 1%

🔗 View Article (PMC 2190350)

Published in J Exp Med on July 01, 1976

Authors

M A Vadas, J F Miller, I F McKenzie, S E Chism, F W Shen, E A Boyse, J R Gamble, A M Whitelaw

Articles citing this

Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J Exp Med (1985) 5.31

Specific Lyt 123 cells are involved in protection against Listeria monocytogenes and in delayed-type hypersensitivity to listerial antigens. J Exp Med (1979) 3.31

Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. I. Failure to collaborate with B cells of the opposite parental strain not associated with active suppression. J Exp Med (1978) 2.34

T cell populations primed by hapten sensitization in contact sensitivity are distinguished by polarized patterns of cytokine production: interferon gamma-producing (Tc1) effector CD8+ T cells and interleukin (Il) 4/Il-10-producing (Th2) negative regulatory CD4+ T cells. J Exp Med (1996) 2.16

Enrichment of specific suppressor T cells and characterization of their surface markers. J Exp Med (1977) 2.13

Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer. J Exp Med (1982) 2.11

The induction of cell-mediated immunity and tolerance with protein antigens coupled to syngeneic lymphoid cells. J Exp Med (1979) 2.09

Suppressor-cell induction in vitro. IV. Target of antigen-specific suppressor factor and its genetic relationships. J Exp Med (1978) 1.77

Specific enrichment of the suppressor T cell bearing I-J determinants: parallel functional and serological characterizations. J Exp Med (1977) 1.70

Interleukin 10 but not interleukin 4 is a natural suppressant of cutaneous inflammatory responses. J Exp Med (1995) 1.68

Functional analysis of T cells expressing Ia antigens. I. Demonstration of helper T-cell heterogeneity. J Exp Med (1979) 1.53

Regulation of granulomatous inflammation in murine schistosomiasis. In vitro characterization of T lymphocyte subsets involved in the production and suppression of migration inhibition factor. J Exp Med (1980) 1.48

An early component of delayed-type hypersensitivity mediated by T cells and mast cells. J Exp Med (1983) 1.45

Specificity, Ly phenotype, and H-2 compatibility requirements of effector cells in delayed-type hypersensitivity responses to murine influenza virus infection. J Exp Med (1980) 1.41

Induction and mode of action of suppressor cells generated against human gamma globulin. I. An immunologic unresponsive state devoid of demonstrable suppressor cells. J Exp Med (1978) 1.29

Appearance of non-specific suppressor T cells during in vitro culture. Immunology (1977) 1.21

Suppressor T cells prevent experimental autoimmune encephalomyelitis in mice. Clin Exp Immunol (1977) 1.19

Expression of Ly 1, Ly 2, Thy 1, and TL differentiation antigens on mouse T-cell tumors. J Exp Med (1978) 1.16

Determination of immune cells and expression of major histocompatibility complex class II antigen in encephalitic lesions of experimental Borna disease. Acta Neuropathol (1990) 1.15

Suppressor T cell memory. II. The role of memory suppressor T cells in tolerance to human gamma globulin. J Exp Med (1983) 1.14

T-cell-specific murine Ia antigens: serology of I-J and I-E subregion specificities. J Exp Med (1978) 1.12

Distinction between suppressors of the delayed-type hypersensitivity and the humoral response to sheep erythrocytes. Immunology (1978) 1.09

Suppressor T cells activated in a primary in vitro response to non-major histocompatibility alloantigens. J Exp Med (1982) 1.04

Tolerance, suppression and the fetal allograft. J Mol Med (Berl) (2004) 1.02

Sequential stages of human T lymphocyte differentiation. Proc Natl Acad Sci U S A (1977) 1.00

Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology (2008) 0.97

In vitro interactions of immune lymphocytes and Cryptococcus neoformans. Infect Immun (1982) 0.95

Induction and mode of action of suppressor cells generated against human gamma globulin. II. Effects of colchicine. J Exp Med (1979) 0.94

Long lived protection against pneumonic tularemia is correlated with cellular immunity in peripheral, not pulmonary, organs. Vaccine (2010) 0.94

Skin test to assess virus-specific cytotoxic T-cell activity. Proc Natl Acad Sci U S A (1992) 0.93

Lyt phenotype and H-2 compatibility requirements of effector cells in the delayed-type hypersensitivity response to dengue virus infection. Infect Immun (1984) 0.90

The role of T cell sets in the rejection of a methylcholanthrene-induced sarcoma (S1509a) in syngeneic mice. Am J Pathol (1981) 0.90

Mononuclear cell pulmonary vasculitis in NZB/W mice. II. Immunohistochemical characterization of the infiltrating cells. Am J Pathol (1986) 0.89

Secretion of Ia antigens by a subpopulation of T cells which are Ly-1+, Ly-2-, and Ia-. J Exp Med (1976) 0.88

Direct visualization of T lymphocytes bearing Ia antigens controlled by the I-J subregion. J Exp Med (1977) 0.85

Role of self carriers in the immune response and tolerance. V. Reversal of trinitrophenyl-modified self suppression of the B-cell response by blocking of H-2 antigens. J Exp Med (1980) 0.84

The surface phenotype of a suppressor cell of delayed-type hypersensitivity in the mouse. Immunology (1980) 0.83

Thymus-derived lymphocytes control the expression of immunogenic properties of peritoneal macrophages. Proc Natl Acad Sci U S A (1979) 0.83

Allospecific suppression without requirement for participation of Ly 2+ cells. Immunology (1984) 0.82

Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers. Mediators Inflamm (2014) 0.81

Acetylcholine receptor-specific suppressive T-cell factor from a retrovirally transformed T-cell line. Proc Natl Acad Sci U S A (1984) 0.81

Adoptive transfer of delayed type hypersensitivity reactions specific for Leishmania major antigens to normal mice using murine T cell populations and clones generated in vitro. Clin Exp Immunol (1984) 0.79

Analysis of defective delayed-type hypersensitivity in autoimmune mice bearing lpr gene. Clin Exp Immunol (1986) 0.79

Ia antigens in serum during different murine infections. Infect Immun (1979) 0.78

High frequency detection of different T-cell subsets in mice by a modified virus plaque assay. Immunology (1983) 0.78

Toward a Network Model of MHC Class II-Restricted Antigen Processing. Front Immunol (2013) 0.78

Demonstration of active tolerance in maintenance of established islet of Langerhans allografts. Proc Natl Acad Sci U S A (1982) 0.77

Lymphocyte chemotaxis in inflammation. VI. Lyt phenotype analysis of effector cells responsible for producing murine lymphocyte chemotactic factor. Immunology (1983) 0.77

Generation of a T-cell hybridoma producing a contrasuppressor factor for contact sensitivity. Immunology (1990) 0.77

Reduction of the number of immunocompetent cells in the acute stage of herpes zoster. Arch Dermatol Res (1987) 0.76

Role of natural killer cells in Pichinde virus infection of Syrian hamsters. Infect Immun (1981) 0.75

Effects of whole-body irradiation on neonatally thymectomized mice. Incidence of benign and malignant tumors. Am J Pathol (1978) 0.75

Articles cited by this

Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology (1968) 24.83

Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med (1975) 17.16

THE AKR THYMIC ANTIGEN AND ITS DISTRIBUTION IN LEUKEMIAS AND NERVOUS TISSUES. J Exp Med (1964) 13.72

Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20

Potentiation of T-cell-mediated immunity by selective suppression of antibody formation with cyclophosphamide. J Exp Med (1974) 5.73

PREPARATION OF PURIFIED ANTI-2,4-DINITROPHENYL ANTIBODIES. Methods Med Res (1964) 5.10

Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse. Nature (1975) 4.34

Evidence for the expression of Ia (H-2-associated) antigens on thymus-derived lymphocytes. J Exp Med (1974) 3.56

T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06

Different Ly antigen phenotypes of in vitro induced helper and suppressor cells. Nature (1975) 2.91

A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64

Ia alloantigen(s) detected on thymocytes by use of a fluorescence-activated cell sorter. J Immunol (1975) 1.65

Dissociation of T cell helper function and delayed hypersensitivity. J Immunol (1974) 1.43

Fc-receptors, Ia-antigens, and immunoglobulin on normal and activated mouse T lymphocytes. J Exp Med (1975) 1.32

Lack of a correlation between cell-mediated immunity to the carrier and the carrier-hapten helper effect. J Exp Med (1974) 1.30

In vitro induction of tumour-specific immunity. I. Development of optimal conditions for induction and assay of cytotoxic lymphocytes. J Immunol Methods (1975) 1.18

The distribution of Ia antigens of the H-2 complex on lymph node cells by immunoferritin labelling. Cell Immunol (1975) 0.89

Articles by these authors

High efficiency transformation of E. coli by high voltage electroporation. Nucleic Acids Res (1988) 34.78

Functional subclasses of T-lymphocytes bearing different Ly antigens. I. The generation of functionally distinct T-cell subclasses is a differentiative process independent of antigen. J Exp Med (1975) 17.16

Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity. J Exp Med (1975) 13.69

Cell to cell interaction in the immune response. II. The source of hemolysin-forming cells in irradiated mice given bone marrow and thymus or thoracic duct lymphocytes. J Exp Med (1968) 12.91

Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (1998) 11.08

Cell to cell interaction in the immune response. I. Hemolysin-forming cells in neonatally thymectomized mice reconstituted with thymus or thoracic duct lymphocytes. J Exp Med (1968) 9.67

Thymus and antigen-reactive cells. Transplant Rev (1969) 8.84

Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc Natl Acad Sci U S A (1985) 8.77

Current concepts of the immunological function of the thymus. Physiol Rev (1967) 8.37

Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J Exp Med (1976) 8.01

Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse. Proc R Soc Lond B Biol Sci (1968) 7.51

Immunological activity of thymus and thoracic-duct lymphocytes. Proc Natl Acad Sci U S A (1968) 7.49

A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47

Expression of T-cell differentiation antigens on effector cells in cell-mediated cytotoxicity in vitro. Evidence for functional heterogeneity related to the surface phenotype of T cells. J Exp Med (1975) 7.20

Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus. Nature (1978) 6.59

Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses. J Exp Med (1966) 6.45

Immunoregulatory circuits among T-cell sets. I. T-helper cells induce other T-cell sets to exert feedback inhibition. J Exp Med (1978) 6.29

The G (Gross) leukemia antigen. Cancer Res (1965) 6.07

The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome. J Exp Med (1971) 6.06

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72

Stimulation of neutrophils by tumor necrosis factor. J Immunol (1986) 5.72

Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52

Immunoregulatory circuits among T-cell sets. II. Physiologic role of feedback inhibition in vivo: absence in NZB mice. J Exp Med (1978) 5.48

A pseudogene homologous to mouse transplantation antigens: transplantation antigens are encoded by eight exons that correlate with protein domains. Cell (1981) 5.43

Constitutive class I-restricted exogenous presentation of self antigens in vivo. J Exp Med (1996) 5.21

Regulation of cellular and humoral immune responses by T-cell subclasses. Cold Spring Harb Symp Quant Biol (1977) 5.21

Surface alloantigens of plasma cells. J Exp Med (1970) 5.19

T-cell regulation of antibody responses: demonstration of allotype-specific helper T cells and their specific removal by suppressor T cells. J Exp Med (1976) 5.11

Cell to cell interaction in the immune response. 3. Chromosomal marker analysis of single antibody-forming cells in reconstituted, irradiated, or thymectomized mice. J Exp Med (1968) 5.02

Lymphocytes as models for the study of mammalian cellular differentiation. Immunol Rev (1977) 5.01

Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78

Antigenic modulation. Loss of TL antigen from cells exposed to TL antibody. Study of the phenomenon in vitro. J Exp Med (1968) 4.63

Recombinant human interleukin 5 is a selective activator of human eosinophil function. J Exp Med (1988) 4.60

Specific inactivation of thymus-derived (T) and non-thymus-derived (B) lymphocytes by 125I-labelled antigen. Nat New Biol (1971) 4.55

Ly antigens as markers for functionally distinct subpopulations of thymus-derived lymphocytes of the mouse. Nature (1975) 4.34

A new method for the purification of human eosinophils and neutrophils, and a comparison of the ability of these cells to damage schistosomula of Schistosoma mansoni. J Immunol (1979) 4.17

Human umbilical cord blood as a potential source of transplantable hematopoietic stem/progenitor cells. Proc Natl Acad Sci U S A (1989) 4.13

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help. J Exp Med (1997) 4.01

Improved complementation in the cytotoxic test. Transplantation (1970) 3.93

The thymus and the precursors of antigen reactive cells. Nature (1967) 3.92

Current enigmas in cancer research. Harvey Lect (1973) 3.91

Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J Clin Invest (1986) 3.78

Role of major histocompatibility complex gene products in delayed-type hypersensitivity. Proc Natl Acad Sci U S A (1976) 3.69

Cellular basis of the immunological defects in thymectomized mice. Nature (1967) 3.69

Ectopic expression of the flagellar regulon alters development of the Bordetella-host interaction. Cell (1995) 3.64

Precipitating antibody in human serum to an antigen present in cultured burkitt's lymphoma cells. Proc Natl Acad Sci U S A (1966) 3.56

Antigenic structure of cell surfaces. An immunoferritin study of the occurrence and topography of H-2' theta, and TL alloantigens on mouse cells. J Exp Med (1969) 3.53

Immunoglobulin and other surface antigens of cells of the immune system. J Exp Med (1971) 3.50

An approach to the mapping of antigens on the cell surface. Proc Natl Acad Sci U S A (1968) 3.46

BvgAS-mediated signal transduction: analysis of phase-locked regulatory mutants of Bordetella bronchiseptica in a rabbit model. Infect Immun (1994) 3.44

Antigens of tumors and leukemias induced by viruses. Fed Proc (1966) 3.43

Ly-C: a third locus specifying alloantigens expressed only on thymocytes and lymphocytes. Transplantation (1971) 3.42

Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35

H-2 gene complex restricts transfer of delayed-type hypersensitivity in mice. Proc Natl Acad Sci U S A (1975) 3.34

Genetic linkage relationships of loci specifying differentiation alloantigens in the mouse. Transplantation (1972) 3.34

Biochemical evidence linking the GIX thymocyte surface antigen to the gp69/71 envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.31

Regeneration of thymus grafts. I. Histological and cytological aspects. Transplantation (1965) 3.29

In-vitro demonstration of thymic hormone in the mouse by conversion of precursor cells into lymphocytes. Lancet (1973) 3.27

Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A (1967) 3.26

Resistance and susceptibility of mice to bacterial infection: genetics of listeriosis. Infect Immun (1978) 3.24

Recognition among mice. Evidence from the use of a Y-maze differentially scented by congenic mice of different major histocompatibility types. J Exp Med (1979) 3.23

Roles for motility in bacterial-host interactions. Mol Microbiol (1997) 3.16

Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16

Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14

Differentiation of T cells induced by preparations from thymus and by nonthymic agents. J Exp Med (1973) 3.12

Relation of GIX antigen of thymocytes to envelope glycoprotein of murine leukemia virus. J Exp Med (1975) 3.06

T cell-dependent suppression of an anti-hapten antibody response. Transplant Rev (1975) 3.06

Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03

Independent differentiative pathways of Ly1 and Ly23 subclasses of T cells. Experimental production of mice deprived of selected T-cell subclasses. J Exp Med (1976) 2.99

Early embryonic mortality in women. Fertil Steril (1982) 2.92

Mouse isoantigens: separation of soluble TL (thymus-leukemia) antigen from soluble H-2 histocompatibility antigen by column chromatography. J Exp Med (1967) 2.86

Contrasuppression. A novel immunoregulatory activity. J Exp Med (1981) 2.84

Snowmobile injuries. Hazards from a popular new winter sport. JAMA (1969) 2.82

Development of an extremely wear-resistant ultra high molecular weight polyethylene for total hip replacements. J Orthop Res (1999) 2.81

Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc Natl Acad Sci U S A (1975) 2.77

G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc Natl Acad Sci U S A (1970) 2.77

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77

Nuclear proteins interacting with the promoter region of the human granulocyte/macrophage colony-stimulating factor gene. Proc Natl Acad Sci U S A (1988) 2.74

Fetal loss after implantation. A prospective study. Lancet (1980) 2.73

Distinctive urinary odors governed by the major histocompatibility locus of the mouse. Proc Natl Acad Sci U S A (1981) 2.68

Dysmyelination in transgenic mice resulting from expression of class I histocompatibility molecules in oligodendrocytes. Nature (1991) 2.67

Screening for receptor ligands using large libraries of peptides linked to the C terminus of the lac repressor. Proc Natl Acad Sci U S A (1992) 2.67

Recombinant Listeria monocytogenes as a live vaccine vehicle for the induction of protective anti-viral cell-mediated immunity. Proc Natl Acad Sci U S A (1995) 2.66

Resistance and susceptibility of mice to bacterial infection: course of listeriosis in resistant or susceptible mice. Infect Immun (1978) 2.65

A radioisotopic method to measure delayed type hypersensitivity in the mouse. I. Studies in sensitized and normal mice. Int Arch Allergy Appl Immunol (1975) 2.64

T-cell lines producing antigen-specific suppressor factor. Nature (1978) 2.63

Use of hybrid antibody with anti-gamma-G and anti-ferritin specificities in locating cell surface antigens by electron microscopy. J Exp Med (1968) 2.62

Compartmentalization of bacterial antigens: differential effects on priming of CD8 T cells and protective immunity. Cell (1998) 2.59